Loading...

PROTAGENIC THERAPEUTICS INC Company Mergers 8-K Filing

PRTG

PROTAGENIC THERAPEUTICS INC

()

2025 8-K

Leadership Appointment

Stock Delisting Notice

Delisting Notification

Director Resignation

Legal Action Filed

Acquisition Update

Company Acquisition

Accounting Changes

Restructuring Plan

Rights Offerings

Warrant Exercises

Warrant Exchange

Asset Acquisitions

Stock Split Approval

Stock Option Repricing

Annual Meeting Results

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Update

Filing with Quantitative Data

Quantitative Data

Annual Meeting Results

Quantitative Data

Reverse Stock Split

External Links:

Protagenic Therapeutics, Inc. reported on September 17, 2025, that it amended its earlier filing regarding the acquisition of Phytanix Bio, which occurred on May 15, 2025, finalizing the financial statements related to the transaction. The deal involved acquiring 100% of Phytanix's shares from Alterola Biotech Inc. and EMC2 Capital LLC.

AI Assistant

PROTAGENIC THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.